Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLCKaiwen Wang, Xiuning Le, Natalie Uy et al.|Journal of Thoracic Oncology|2023Cited by 26
DLL3 Immunohistochemical Expression in Neuroendocrine-Transformed EGFR-Mutant Lung Cancer and Two Cases of Tarlatamab TherapyJacqueline V. Aredo, Jonathan W. Riess, Surbhi Singhal et al.|JTO Clinical and Research Reports|2025Cited by 1